Literature DB >> 24961872

The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care.

M P Jones1, M M Walker, A C Ford, N J Talley.   

Abstract

BACKGROUND: Activation of the immune system has been demonstrated in atopy and functional gastrointestinal disorders (FGIDs). Previous data from our group have suggested a connection between immune dysregulation, FGIDs and mood disorders. AIM: To investigate if these data translate to clinical practice and examine connections from the perspective of FGIDs to determine whether atopy and FGIDs are connected via mood disorders.
METHODS: Evidence of irritable bowel syndrome (IBS), functional dyspepsia (FD) and constipation was sought from the medical records of 30,000 primary care records over a minimum 5 year period. The same records yielded diagnoses of four atopic conditions (asthma, eczema, allergic rhinitis/hay fever and conjunctivitis).
RESULTS: Atopic conditions were found in excess among all FGID groups considered when compared with controls. In the groups with IBS alone (OR = 1.43, 1.29-1.58), FD alone (OR = 1.41, 1.26-1.58) and those with multiple FGIDs (OR = 1.92, 1.75-2.12) there was elevated prevalence of asthma compared with controls without a FGID. Across disorders the excess was generally highest among patients diagnosed with multiple FGIDs (rhinitis/hay fever OR = 3.74, 3.32-4.20; conjunctivitis OR = 3.00, 2.49-3.62) and was only partly explained by a common association between both FGIDs and atopic conditions with mood disorders, although not for every atopic/FGID combination (rhinitis/hay fever OR = 2.60, 2.29-2.96, conjunctivitis OR = 2.34, 1.90-2.87).
CONCLUSIONS: Irritable bowel syndrome, functional dyspepsia and constipation share an association with atopy that is only partly explained via a common connection with mood disorders. These data have important implications for understanding both the pathophysiology of functional gastrointestinal disorders and development of new treatments.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24961872     DOI: 10.1111/apt.12846

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  27 in total

Review 1.  Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity.

Authors:  Pasquale Mansueto; Alberto D'Alcamo; Aurelio Seidita; Antonio Carroccio
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

2.  Nickel sensitization in patients with gastro-esophageal reflux disease.

Authors:  Vincenzo Stanghellini; Cesare Tosetti; Edoardo Benedetto; Mario Condoluci; Rudi De Bastiani; Rosanna Cogliandro; Tecla Mastronuzzi; Manuela De Polo; Francesco Di Mita; Luigi Napoli; Enzo Ubaldi; Cristina Nebiacolombo; Carmelo Cottone; Ignazio Grattagliano; Maria Zamparella; Elisabetta Baldi; Guido Sanna
Journal:  United European Gastroenterol J       Date:  2015-07-24       Impact factor: 4.623

Review 3.  Functional Dyspepsia in the Elderly.

Authors:  Marjorie M Walker; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2019-11-13

4.  Immune Activation in Functional Gastrointestinal Disorders.

Authors:  Grace Burns; Jennifer Pryor; Gerald Holtmann; Marjorie M Walker; Nicholas J Talley; Simon Keely
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-10

5.  The frequency of and factors affecting functional gastrointestinal disorders in infants that presented to tertiary care hospitals.

Authors:  Omer Faruk Beser; Fugen Cullu Cokugras; Guzide Dogan; Ozlem Akgun; Murat Elevli; Pinar Yilmazbas; Meric Ocal; Nevzat Aykut Bayrak; Rabia Gonul Sezer Yamanel; Abdulkadir Bozaykut; Coşkun Celtik; Esra Polat; Nelgin Gerenli; Serdar Bozlak; Hasret Ayyildiz Civan; Neslihan Ozkul Saglam; Sadik Sami Hatipoglu; Gamze Özgürhan; Eda Sunnetci Silistre; Burcu Solmaz; Gunsel Kutluk; Hamide Sevinc Genc; Hasan Onal; Ayse Merve Usta; Nafiye Urganci; Ayse Sahin; Sebahat Cam; Sema Yildirim; Asilay Yildirim; Yvan Vandenplas
Journal:  Eur J Pediatr       Date:  2021-04-03       Impact factor: 3.183

Review 6.  Immune activation in irritable bowel syndrome: what is the evidence?

Authors:  Javier Aguilera-Lizarraga; Hind Hussein; Guy E Boeckxstaens
Journal:  Nat Rev Immunol       Date:  2022-03-16       Impact factor: 53.106

Review 7.  Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.

Authors:  Nicholas J Talley; Gerald Holtmann; Marjorie M Walker
Journal:  J Gastroenterol       Date:  2015-04-29       Impact factor: 7.527

Review 8.  Immunoglobulin E in irritable bowel syndrome: another target for treatment? A case report and literature review.

Authors:  James S Pearson; Robert M Niven; Jie Meng; Sima Atarodi; Peter J Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2015-09       Impact factor: 4.409

9.  Functional Gastrointestinal Symptoms Are Associated with Higher Serum Total IgE Levels, but Less Atopic Sensitization.

Authors:  Ellen Johanne Vara; Cecilie Svanes; Trude D Skorge; Aud Berstad; Erik Florvaag; Debbie Jarvis; Ernst Omenaas; Marie Waatevik; Ane Johannessen; Gülen Arslan Lied
Journal:  Dig Dis Sci       Date:  2015-08-12       Impact factor: 3.199

10.  Local immune response to food antigens drives meal-induced abdominal pain.

Authors:  Javier Aguilera-Lizarraga; Morgane V Florens; Maria Francesca Viola; Piyush Jain; Lisse Decraecker; Iris Appeltans; Maria Cuende-Estevez; Naomi Fabre; Kim Van Beek; Eluisa Perna; Dafne Balemans; Nathalie Stakenborg; Stavroula Theofanous; Goele Bosmans; Stéphanie U Mondelaers; Gianluca Matteoli; Sales Ibiza Martínez; Cintya Lopez-Lopez; Josue Jaramillo-Polanco; Karel Talavera; Yeranddy A Alpizar; Thorsten B Feyerabend; Hans-Reimer Rodewald; Ricard Farre; Frank A Redegeld; Jiyeon Si; Jeroen Raes; Christine Breynaert; Rik Schrijvers; Cédric Bosteels; Bart N Lambrecht; Scott D Boyd; Ramona A Hoh; Deirdre Cabooter; Maxim Nelis; Patrick Augustijns; Sven Hendrix; Jessica Strid; Raf Bisschops; David E Reed; Stephen J Vanner; Alexandre Denadai-Souza; Mira M Wouters; Guy E Boeckxstaens
Journal:  Nature       Date:  2021-01-13       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.